TTM
$11.13B
YoY change
-27.9%
5Y CAGR
-10.4%
Peak year (2023)
$18.20B
Cumulative EBITDA
$244.67B
EBITDA history chart for CVS Health (CVS) from 1985 to 2025
Latest: $9.86B
EBITDA growth chart for CVS Health (CVS) from 1985 to 2025
Latest: -27.9%
EBITDA history table for CVS Health (CVS) from 1985 to 2025
| 2025 | $9.86B | -27.9% | −$3.82B | ||
| 2024 | $13.68B | -24.8% | −$4.51B | ||
| 2023 | $18.20B | +47.4% | +$5.85B | ||
| 2022 | $12.35B | -29.6% | −$5.18B | ||
| 2021 | $17.53B | +2.4% | +$408.00M | ||
| 2020 | $17.12B | +4.4% | +$715.00M | ||
| 2019 | $16.40B | +143.3% | +$9.66B | ||
| 2018 | $6.74B | -42.9% | −$5.07B | ||
| 2017 | $11.81B | -3.1% | −$381.00M | ||
| 2016 | $12.19B | +5.4% | +$623.00M | ||
| 2015 | $11.57B | +13.1% | +$1.34B | ||
| 2014 | $10.22B | +3.1% | +$309.00M | ||
| 2013 | $9.91B | +15.0% | +$1.30B | ||
| 2012 | $8.62B | +9.1% | +$716.00M | ||
| 2011 | $7.90B | +3.9% | +$294.00M | ||
| 2010 | $7.61B | -2.7% | −$210.00M | ||
| 2009 | $7.82B | +6.5% | +$478.00M | ||
| 2008 | $7.34B | +24.7% | +$1.45B | ||
| 2007 | $5.89B | +85.5% | +$2.71B | ||
| 2006 | $3.17B | +21.7% | +$566.30M | ||
| 2005 | $2.61B | +33.7% | +$657.10M | ||
| 2004 | $1.95B | +10.5% | +$186.20M | ||
| 2003 | $1.77B | +16.4% | +$248.80M | ||
| 2002 | $1.52B | +5.0% | +$72.60M | ||
| 2001 | $1.44B | -10.8% | −$175.40M | ||
| 2000 | $1.62B | +14.6% | +$205.90M | ||
| 1999 | $1.41B | +19.8% | +$233.20M | ||
| 1998 | $1.18B | +24.7% | +$233.50M | ||
| 1997 | $946.70M | +9.1% | +$79.20M | ||
| 1996 | $867.50M | +19.8% | +$143.60M | ||
| 1995 | $723.90M | -11.4% | −$93.10M | ||
| 1994 | $817.00M | +0.3% | +$2.10M | ||
| 1993 | $814.90M | +45.0% | +$253.00M | ||
| 1992 | $561.90M | -30.5% | −$246.20M | ||
| 1991 | $808.10M | +3.8% | +$29.50M | ||
| 1990 | $778.60M | +2.6% | +$19.90M | ||
| 1989 | $758.70M | +12.9% | +$86.90M | ||
| 1988 | $671.80M | +12.8% | +$76.20M | ||
| 1987 | $595.60M | +8.8% | +$48.00M | ||
| 1986 | $547.60M | +6.9% | +$35.50M | ||
| 1985 | $512.10M | — | — |
- 2025$9.86B-27.9%
- 2024$13.68B-24.8%
- 2023$18.20B+47.4%
- 2022$12.35B-29.6%
- 2021$17.53B+2.4%
- 2020$17.12B+4.4%
- 2019$16.40B+143.3%
- 2018$6.74B-42.9%
- 2017$11.81B-3.1%
- 2016$12.19B+5.4%
- 2015$11.57B+13.1%
- 2014$10.22B+3.1%
- 2013$9.91B+15.0%
- 2012$8.62B+9.1%
- 2011$7.90B+3.9%
- 2010$7.61B-2.7%
- 2009$7.82B+6.5%
- 2008$7.34B+24.7%
- 2007$5.89B+85.5%
- 2006$3.17B+21.7%
- 2005$2.61B+33.7%
- 2004$1.95B+10.5%
- 2003$1.77B+16.4%
- 2002$1.52B+5.0%
- 2001$1.44B-10.8%
- 2000$1.62B+14.6%
- 1999$1.41B+19.8%
- 1998$1.18B+24.7%
- 1997$946.70M+9.1%
- 1996$867.50M+19.8%
- 1995$723.90M-11.4%
- 1994$817.00M+0.3%
- 1993$814.90M+45.0%
- 1992$561.90M-30.5%
- 1991$808.10M+3.8%
- 1990$778.60M+2.6%
- 1989$758.70M+12.9%
- 1988$671.80M+12.8%
- 1987$595.60M+8.8%
- 1986$547.60M+6.9%
- 1985$512.10M—
EBITDA values are taken from CVS Health's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at CVS Health (CVS)
According to CVS Health's latest reported financial statements, the company's current EBITDA (TTM) is $11.13B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual EBITDA for CVS Health (CVS) came in at $9.86B – declined 27.9% year-over-year.
CVS Health EBITDA compound annual growth for the 2020–2025 (5 years) window is -10.4%, with a net decline across the window.
Between 2023 and 2025, CVS Health EBITDA plunged 45.8%, falling from $18.20B to $9.86B.
The highest annual EBITDA of $18.20B was reported in 2023. The lowest in the available history was $512.10M in 1985.
CVS Health EBITDA by Year
CVS Health EBITDA 2025: $9.86B
CVS Health posted EBITDA of $9.86B in 2025, declined 27.9% below 2024.
CVS Health EBITDA 2024: $13.68B
In 2024, CVS Health reported EBITDA of $13.68B, declined 24.8% below 2023.
CVS Health EBITDA 2023: $18.20B
CVS Health EBITDA in 2023 was $18.20B, surged 47.4% from 2022. This figure represents the highest annual value in the available history.
CVS Health EBITDA 2022: $12.35B
2022's EBITDA for CVS Health came in at $12.35B, declined 29.6% below 2021.
CVS Health EBITDA 2021: $17.53B
CVS Health EBITDA in 2021 was $17.53B.
See more financial history for CVS Health (CVS).
Sector peers by EBITDA
Healthcare peers of CVS Health (CVS), ranked by their latest EBITDA
| $41.05B | |
| $28.26B | |
| $27.94B | |
| $24.43B | |
| $23.06B | |
| $19.83B | |
| $17.63B | |
| $16.90B |
- $41.05B
- $28.26B
- $27.94B
- $24.43B
- $23.06B
- $19.83B
- $17.63B
- $16.90B
Frequently asked questions
CVS Health (CVS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation